Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Aditx Therapeutics to Present at H.C. Wainwright 22nd Annual


GlobeNewswire Inc | Sep 10, 2020 04:30PM EDT

September 10, 2020

Virtual Presentation on Wednesday, September 16th at 3:00 PM EDT

Loma Linda, CA, Sept. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the "Company") (NASDAQ:ADTX), a life sciences company developing biotechnologies focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it will be presenting at the H.C. Wainwright 22nd Annual Global Investment Conference being held virtually from September 14-16, 2020. The presentation is scheduled for Wednesday, September 16th at 3:00 PM EDT.

Amro Albanna, Co-founder and Chief Executive Officer of Aditxt, will be presenting a corporate overview to a live audience and will be available for virtual one-on-one meetings with investors throughout the conference.

The presentation will be webcast live and may be accessed by following this link: https://wsw.com/webcast/hcw7/adtx/1609577

About Aditx Therapeutics

Aditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. The immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system. The immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. For more information, please visitwww.aditxt.com.

Forward-Looking Statements

Certain statements in this press release constitute forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include statements regarding the Companys intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the Companys ongoing and planned product development; the Companys intellectual property position; the Companys ability to develop commercial functions; expectations regarding product launch and revenue; the Companys results of operations, cash needs, spending, financial condition, liquidity, prospects, growth and strategies; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as those risks more fully discussed in the section entitled Risk Factors in the Companys prospectus, dated September 1, 2020, that was filed with the U.S. Securities and Exchange Commission under File No. 333-248491, as well as discussions of potential risks, uncertainties, and other important factors in the Companys subsequent filings with the U.S. Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:PCG Advisory Jeff Ramson Chief Executive Officer 646-762-4518 IR@aditxt.com www.aditxt.com







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC